Increasing uptake of live attenuated influenza vaccine among children in the United States, 2008-2014.

The Advisory Committee on Immunization Practices (ACIP) recommends annual influenza vaccination for all persons in the United States aged ≥6 months. On June 25, 2014, ACIP preferentially recommended live attenuated influenza vaccine (LAIV) for healthy children aged 2-8 years. Little is known about national LAIV uptake. To determine uptake of LAIV relative to inactivated influenza vaccine, we analyzed vaccination records from six immunization information system sentinel sites (approximately 10% of US population). LAIV usage increased over time in all sites. Among children 2-8 years of age vaccinated for influenza, exclusive LAIV usage in the collective sentinel site area increased from 20.1% (2008-09 season) to 38.0% (2013-14). During 2013-14, at least half of vaccinated children received LAIV in Minnesota (50.0%) and North Dakota (55.5%). Increasing LAIV usage suggests formulation acceptability, and this preexisting trend offers a favorable context for implementation of ACIP's preferential recommendation.

[1]  B. Luce,et al.  Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. , 2008, Vaccine.

[2]  C. Bridges,et al.  Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons. , 2013, Morbidity and mortality weekly report. Surveillance summaries.

[3]  Lucia H. Lee,et al.  Recommendations for Prevention and Control of Influenza in Children, 2013–2014 , 2013, Pediatrics.

[4]  C. Weinbaum,et al.  Seasonal influenza vaccination coverage among children aged 6 months-18 years --- eight immunization information system sentinel sites, United States, 2009-10 influenza season. , 2010, MMWR. Morbidity and mortality weekly report.

[5]  C. Ambrose,et al.  A Prospective Observational Study of US In-office Pediatric Influenza Vaccination During the 2007 to 2009 Influenza Seasons: Use and Factors Associated With Increased Vaccination Rates , 2010, Clinical pediatrics.

[6]  L. Grohskopf,et al.  Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season , 2017, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[7]  R. Walker,et al.  Live attenuated versus inactivated influenza vaccine in infants and young children. , 2007, The New England journal of medicine.

[8]  W. Gruber,et al.  Superior Relative Efficacy of Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine in Young Children With Recurrent Respiratory Tract Infections , 2006, The Pediatric infectious disease journal.